The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 709
Marciano, S., Gutierrez‐Acevedo, M. N., Barbero, S., Notari, L. D. C., Agozino, M., Fernandez, J. L., Anders, M. M., Grigera, N., Antinucci, F., Ganem, O. O., et al. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04572-2 · Cited by 7
Boustany, A. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0794 · Cited by 7
Preventing Future Infections in Cirrhosis: A Battle Cry for Stewardship
Ge, P. S., & Runyon, B. A. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.025 · Cited by 7
Stallmach, A., Hagel, S., Bruns, T., Pletz, M. W., & Eckmann, C. (2013) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0033-1335043 · Cited by 7
Unresolved issues in the prophylaxis of bacterial infections in cirrhosis patients
Dirchwolf, M., Marciano, S., Martínez, J. E., & Ruf, A. E. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i12.892 · Cited by 7
Management of liver cirrhosis in patients with hepatocellular carcinoma.
Ismail, B. S., & Cabrera, R. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2013.09.03 · Cited by 7
Spontaneous bacterial peritonitis
García–Tsao, G. (2012) · doi:10.1002/9781118321386.ch100 · Cited by 7
When to use antibiotics in the cirrhotic patient? The evidence base.
Anastasiou, J., & Williams, R. L. (2013) · Europe PMC (PubMed Central) · Cited by 6
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice
Ferrarese, A., Passigato, N., Cusumano, C., Gemini, S., Tonon, A., Dajti, E., Marasco, G., Ravaioli, F., & Colecchia, A. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i8.840 · Cited by 9
Pampalone, M., Vitale, G., Gruttadauria, S., Amico, G., Iannolo, G., Douradinha, B. G., Mularoni, A., Conaldi, P. G., & Pietrosi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020857 · Cited by 6
Outcome of Intermittent Thoracentesis versus Pigtail Catheter Drainage for Hepatic Hydrothorax
Han, S. K., Kang, S., Kim, M. Y., Na, S. K., Kim, T. H., Lee, M., Jun, B.-G., Kim, T. S., Choi, D. H., Suk, K. T., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237221 · Cited by 6
Ascites in cirrhotic patients: a comprehensive review
Carrier, P., Loustaud-Ratti, V., Debette‐Gratien, M., & Elkrief, L. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00056 · Cited by 6
The management of patients awaiting liver transplantation
Li, K., & Neuberger, J. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.163 · Cited by 6
Antibiotika und der Gastrointestinaltrakt
Lübbert, C. (2015) · Gastroenterologie up2date · doi:10.1055/s-0034-1392718 · Cited by 6
Wu, P.-S., Wang, Y.-W., Tai, C.-C., Hsieh, Y., Lee, P., Huang, C., Huang, Y., Hou, M., Lin, H., & Lee, K. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000422 · Cited by 6
Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents
Zaccherini, G., Tufoni, M., Bernardi, M., & Caraceni, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194590 · Cited by 7
Chronic Kidney Disease After Liver Transplantation
Minjares, R. O., Martin, P. B., & Carrion, A. F. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.01.006 · Cited by 6
Hooper, D. C., & Strahilevitz, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00035-7 · Cited by 6
Spontaneous Bacterial Peritonitis
Jawid, A. W. R., & Subramanian, I. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_68 · Cited by 6
Pillebout, É. (2014) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2013.11.005 · Cited by 6
Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis
Ginès, P., Cárdenas, A., Arroyo, V., & Rodés, J. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch38 · Cited by 6
Self-citationWang, M. Y., Wong, V. W., & Yip, T. C. (2023) · Liver International · doi:10.1111/liv.15696 · Cited by 6
Evidence-Based Commentary: Antibiotics for Prophylaxis of Spontaneous Bacterial Peritonitis
Fatima, I., & Kulkarni, A. V. (2022) · JOURNAL OF GASTROINTESTINAL INFECTIONS · doi:10.1055/s-0042-1757543 · Cited by 6
Kim, Y. S. (2010) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2010.56.3.168 · Cited by 5
Shizuma, T. (2014) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000166 · Cited by 5
Bacteremia in cirrhotic patients with upper gastrointestinal bleeding
Shih, H.-A., Tsai, P.-C., Wu, K.-H., Chen, Y., & Chen, Y.-C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17309 · Cited by 5
Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics
Banc‐Husu, A. M., Shiau, H. H., Dike, P. N., & Shneider, B. L. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1759613 · Cited by 5
Dawit, L., Lee, V., Lehoang, D., Furey, C., Chowdhury, A. R., Anne, T., Angajala, V. T., Park, J. H., Khadarian, K. A., She, R. C., et al. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000614 · Cited by 5
Chang, G., Sun, J., Li, J., & Li, T. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102361 · Cited by 6
Albillos, A., Bañares, R., Hernández–Gea, V., Alvarado‐Tápias, E., Ampuero, J., Baiges, A., Bellot, P., Calleja, J. L., Cárdena, A., Catalina, M.-V., et al. (2024) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2024.502208 · Cited by 5
Impact of hepatorenal syndrome and liver transplantation
Memon, I. A., & Klein, C. L. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328346576c · Cited by 5
Improving quality of care in patients with cirrhosis
Kanwal, F., & El‐Serag, H. B. (2013) · Clinical Liver Disease · doi:10.1002/cld.189 · Cited by 5
Spontaneous Bacterial Peritonitis
Horinek, E. L., & Fish, D. (2009) · AACN Advanced Critical Care · doi:10.1097/nci.0b013e3181a0b3b6 · Cited by 5
Rahma, M. Z. A., Mahran, Z. G., Shafik, E. A., Mohareb, D. A., el‐Rady, N. M. A., Mustafa, M. A., Khalil, M., Abo-Amer, Y. E.-E., & Abd-Elsalam, S. M. (2020) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523019666200303104932 · Cited by 5
Problemas actuales en la prevención y tratamiento de las infecciones en pacientes con cirrosis
Bellot, P., López, N. J. P., Martínez‐Moreno, B., & Such, J. M. (2010) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2010.02.004 · Cited by 5
Self-citationSpontaneous bacterial peritonitis: Few additional points
Jain, P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5754 · Cited by 5
Current Therapies for Hepatorenal Syndrome
Bonder, A., Botero, M. L., & Cárdenas, A. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0217-7 · Cited by 4
Renal failure in chronic liver disease and the hepatorenal syndrome
Srivastava, B., & Alexander, G. (2011) · British Journal of Hospital Medicine · doi:10.12968/hmed.2011.72.9.497 · Cited by 4
Cirrhosis of the Liver and Its Complications
Kochar, R., Arguedas, M. R., & Fallon, M. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6109-0.00045-9 · Cited by 4
Huschak, G., Kaisers, U. X., & Laudi, S. (2013) · Der Anaesthesist · doi:10.1007/s00101-013-2197-3 · Cited by 4
A guide to diagnosing and managing ascites in cirrhosis
Faisal, F. (2021) · The Journal of Family Practice · doi:10.12788/jfp.0186 · Cited by 4
Eberhard, C. M., Davis, K., & Nisly, S. A. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac041 · Cited by 4
Roy, P., Minhaz, N., Shah-Riar, P., Simona, S. Y., Tasha, T., Hasan, T. B., Abbasi, F. K., Alam, F., Nila, S. A., Akter, J., et al. (2023) · Cureus · doi:10.7759/cureus.43073 · Cited by 4
Arzivian, A., & Duong, T. D. (2023) · Cureus · doi:10.7759/cureus.50191 · Cited by 4
Spontán bakteriális peritonitis
Velkey, B., Vitális, E., & Vitális, Z. (2017) · Orvosi Hetilap · doi:10.1556/650.2017.30637 · Cited by 4
Acute and Chronic Liver Disease
Marik, P. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-11020-2_34 · Cited by 4
Infeções bacterianas no doente com cirrose hepática
Carrola, P., Militão, I., & Presa, J. (2013) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpg.2012.09.008 · Cited by 4
Minuk, G. Y., Hawkins, K., Kaita, K., Wong, S., Renner, E. L., Minuk, L. A., & Uhanova, J. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1456-2 · Cited by 4
Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites
Piano, S. S., Morando, F., & Angeli, P. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_51 · Cited by 4
Christopher, R., & Peura, D. A. (2008) · Cited by 4
García–Tsao, G. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch9 · Cited by 4
Lin, J., Qian, B., Li, Z., Chen, J., Gao, K., Li, Q., Shen, J., Shen, R. D., Guo, Y., & Hua, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115909 · Cited by 3
Antibiotics in decompensated liver disease – who, when and for how long?
Haedge, F., & Bruns, T. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2464044 · Cited by 4
Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015
Wiegand, J., van Bömmel, F., Duarte‐Rojo, A., Altamirano, J., Abraldeṣ, J. G., Villanueva, A., & Berg, T. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.020 · Cited by 3
Guarner, C., & Runyon, B. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-06397-5.00030-7 · Cited by 3
Spontaneous Bacterial Peritonitis and Secondary Bacterial Peritonitis—a Comprehensive Review
Kuftinec, G. N., Estrada, J. R., & Bhamidimarri, K. R. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00551-9 · Cited by 3
García-Saenz-de-Sicilia, M., Al-Obaid, L., Hughes, D. L., & Duarte‐Rojo, A. (2022) · Seminars in Liver Disease · doi:10.1055/a-1886-5909 · Cited by 3
Choi, J. C., & Yoo, J. (2023) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2023.108 · Cited by 3
Inpatient management of bacterial infections in patients with cirrhosis: A clinical review
Chen, G. T., & To, U. K. (2024) · Clinical Liver Disease · doi:10.1097/cld.0000000000000214 · Cited by 3
Hepatorenal Syndrome: Diagnosis and Treatment – newsreel –
Enescu, A., Petrescu, F., Mitruț, P., Petrescu, I. O., Pădureanu, V., & Enescu, A. Ş. (2016) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2016-0024 · Cited by 3
Care of the Liver Transplant Candidate
Tan, H.-H., & Martin, P. B. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.08.005 · Cited by 4
Chronic Kidney Disease and Liver Disease
Junghare, M. Y., & Ibrahim, H. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00045-7 · Cited by 3
Novel Targets and Drug Development in Portal Hypertension
Schierwagen, R., Klein, S., Uschner, F. E., & Trebicka, J. (2019) · Current Hepatology Reports · doi:10.1007/s11901-019-00462-4 · Cited by 3
Ghafar, A. A., Rozaik, S. E., & Akef, A. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_6_19 · Cited by 3
Agrawal, R. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0415 · Cited by 3
Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis
Juanola, A., Solé, C., Toapanta, D., Ginès, P., & Solà, E. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.01.011 · Cited by 3
Self-citationSpontaneous Bacterial Peritonitis
Ohri, A., & Subramanian, I. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_74 · Cited by 3
Spontaneous bacterial peritonitis and other infections
Gustot, T., & Moreau, R. (2015) · Wiley eBooks · doi:10.1002/9781118412640.ch15 · Cited by 3
Lachlan, N., & Fallowfield, J. A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13206 · Cited by 3
Arroyo, V., Fernández, J., Mas, A., & Escorsell, À. (2008) · Hepatology · doi:10.1002/hep.22325 · Cited by 3
Self-citationNew findings about an ‘old’ drug: Immunomodulatory effects of norfloxacin in cirrhosis
Gustot, T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.028 · Cited by 3
Delisting of liver transplant candidates because of bacterial sepsis
Cárdenas, A., & Gustot, T. (2015) · Liver Transplantation · doi:10.1002/lt.24174 · Cited by 3
Ensaroğlu, F., Korkmaz, M., Geçkil, A. Ü., Öcal, S., Koç, B., Yıldız, Ö., Atalay, F. B., TAŞ, E. G., & Haberal, M. A. (2015) · Experimental and Clinical Transplantation · doi:10.6002/ect.tdtd2015.p71 · Cited by 3
Younes, A. Y. M., Abd-Elsalam, S. M., Attia, G. F., & Shehata, M. A. H. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00106-7 · Cited by 2
Elsabaawy, M., Assem, M., Badran, H. M., Mahmoud, A., Elsabaawy, D. M., & Ragab, A. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002797 · Cited by 2
Albillos, A., Bañares, R., & Hernández–Gea, V. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2024.502208 · Cited by 2
Malvi, A., Verma, N., Khatib, M. N., Ganesan, S., Kaur, M., Srivastava, M., Barwal, A., Prasad, G. V. S., Rajput, P., Syed, R., et al. (2025) · JGH Open · doi:10.1002/jgh3.70148 · Cited by 2
Silvey, S. G., Patel, N., O'Leary, J. G., Morgan, T. R. M., Markley, J. D., Jakab, S., Patton, H. M., Rogal, S., & Bajaj, J. S. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70498 · Cited by 2
Hepatorenal syndrome: a decade later.
Pandey, C. K., Karna, S. T., Singh, A., Pandey, V., Tandon, M., & Saluja, V. (2014) · PubMed · Cited by 2
Masnou, H., Aguilar, A., Iborra, I., Sala, M., Torner, M., Clos, A., Ardèvol, A., Giménez, M., Fortuny, M., Sarrias, M., et al. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.09.001 · Cited by 2
Dibos, M., Mayr, U., Triebelhorn, J., Schmid, R. M., & Lahmer, T. (2024) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-024-01168-2 · Cited by 2
Aislamiento de Candida spp. en ascitis de pacientes con cirrosis hepática
Saludes, P., Araguás, C., Sánchez‐Delgado, J., Dalmau, B., & Font, B. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.05.008 · Cited by 2
Berchid-Debdi, M., Chaves, V. M., Rodríguez, C., & Muñoz, J. M. (2012) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2012.03.006 · Cited by 2
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-2-336_4 · Cited by 2
Azzopardi, N., Fenech, M., & Piscopo, T. V. (2012) · InTech eBooks · doi:10.5772/49962 · Cited by 2
Bacterial infections in patients with liver cirrhosis
Zaccherini, G., Bevilacqua, V., Benazzi, B., Santi, L., Caraceni, P., & Bernardi, M. (2011) · Reviews in Health Care · doi:10.7175/rhc.2923147-159 · Cited by 2
Bacterial Translocation and Alterations of the Digestive System
Wiest, R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_10 · Cited by 2
Infection spontanée du liquide d’ascite au cours de la cirrhose
Nousbaum, J. (2015) · La Presse Médicale · doi:10.1016/j.lpm.2015.07.017 · Cited by 2
Study on ascitic fluid protein level in cirrhotic patients with spontaneous bacterial peritonitis
Mustafa, M. G., Mamun, M. A., & Alam, A. K. M. K. (2009) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v35i2.3023 · Cited by 2
Hepatorenal Syndrome: A Comprehensive Overview for the Critical Care Nurse
Fleming, J. N., & Abbass, A. A. (2010) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2010.03.001 · Cited by 2
Pathophysiologic basis for the medical management of portal hypertension
Poordad, F. F., Sigal, S. H., & Brown, R. S. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802707853 · Cited by 2
Complications of Liver Cirrhosis
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_26 · Cited by 2
Le syndrome hépatorénal : mise au point
Gueutin, V., Meftah, A., Desbuissons, G., Debchi, L., Langlois, A., Shehwaro, N., & Izzedine, H. (2013) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2013.05.002 · Cited by 2
An Update on Hepatorenal Syndrome
Chan, S., Au, K., Francis, R. S., Mudge, D. W., Johnson, D. W., & Rahman, T. M. (2017) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.2017.12 · Cited by 2
Antibiotic Prophylaxis and Management of Bacterial Infections
Lim, J. K., Tandon, P., & García–Tsao, G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_20 · Cited by 2
Hsieh, Y., Lee, M., Lee, K., Yang, Y., Hou, M., & Lin, H. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.013 · Cited by 2
Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention
Oliver, A., Wong, M., & Sanchez, C. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000887 · Cited by 2
Ascites and spontaneous bacterial peritonitis
Hu, K., Avanesyan, A., & Runyon, B. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1725-9.10011-5 · Cited by 2
Ginès, P., Cárdenas, A., & Schrier, R. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00079-3 · Cited by 2
Self-citationPuente, Á., Fortea, J. I., Huelin, P., & Crespo, J. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.04.002 · Cited by 2
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
